Trademark: 79201532
Word
BEGESAND
Status
Dead
Status Code
709
Status Date
Friday, July 26, 2024
Serial Number
79201532
Registration Number
5372122
Registration Date
Tuesday, January 9, 2018
Mark Type
4
Filing Date
Thursday, September 8, 2016
Published for Opposition
Tuesday, October 24, 2017
Cancellation Date
Friday, July 26, 2024

Trademark Owner History
ADIENNE SA - Original Registrant

Classifications
5 Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, and substances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; monoclonal antibodies for immunomodulatory treatments, in particular for the treatment of diseases mediated by the differentiation cluster 26 molecule CD26; pharmaceutical preparations comprising as active ingredient monoclonal antibodies having immunomodulatory effects, in particular for the treatment of diseases mediated by the 26 differentiation cluster molecule CD26; dietetic foods, namely, yogurt and rice-derived products, namely, rice flour adapted for medical use, dietetic beverages adapted for medical use, food supplements, enzyme food supplements, protein food supplements, protein supplements for animals, by-products of the processing of cereals for dietetic or medical use, biological preparations for medical use, biological preparations for veterinary use, pills for medicines, namely, immunosuppressant pills, chemical preparations for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, chemical preparations for veterinary use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, biological tissue cultures for medical use, biological tissue cultures for veterinary use, enzyme preparations for medical use, enzyme preparations for veterinary use, enzymes for medical use, enzymes for veterinary use, medicines for veterinary use for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for veterinary use, namely, monoclonal antibodies for immunomodulatory treatments, vaccines, veterinary products in the nature of anti-infective products for veterinary use; living tissue grafts, surgical implants composed of living tissue, radiological contrast substances for medical use, diagnostic preparations for medical use, biomarker reagents for diagnosis for medical use, adjuvants for medical use, chemical preparations for pharmaceutical use, drugs for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations, namely, elixirs for treating viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, plant extracts for pharmaceutical use, medicinal infusions for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, lotions for pharmaceutical use, medicines or human medicine for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for human medicine in the nature of solution for injection for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, syrups for pharmaceutical use for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders
10 Surgical, medical, dental and veterinary apparatus and instruments, namely, infusion bag, vial, syringe; needles for medical use, medical apparatus and instruments, containers for applying medicines, namely, infusion bag, vial, syringe, hypodermic syringes, syringes for medical use, pumps for medical use, namely, infusion pump

Trademark Events
Feb 16, 2017
Sn Assigned For Sect 66a Appl From Ib
Feb 25, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 24, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 17, 2017
New Application Office Supplied Data Entered
Feb 17, 2017
Assigned To Examiner
Feb 21, 2017
Application Filing Receipt Mailed
Feb 24, 2017
Non-Final Action Written
Feb 28, 2017
Refusal Processed By Mpu
Feb 28, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Mar 18, 2017
Refusal Processed By Ib
Jul 24, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 24, 2017
Published For Opposition
Aug 2, 2017
Teas Response To Office Action Received
Aug 23, 2017
Assigned To Lie
Aug 29, 2017
Correspondence Received In Law Office
Aug 29, 2017
Teas/Email Correspondence Entered
Sep 19, 2017
Approved For Pub - Principal Register
Oct 4, 2017
Notification Of Notice Of Publication E-Mailed
Oct 4, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 4, 2017
Notification Of Possible Opposition Sent To Ib
Oct 21, 2017
Notification Processed By Ib
Oct 24, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2018
Registered-Principal Register
Apr 9, 2018
Final Disposition Notice Created, To Be Sent To Ib
Apr 16, 2018
Final Disposition Notice Sent To Ib
Jan 9, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 26, 2024
Cancelled Section 71
Dec 31, 2021
New Representative At Ib Received
Apr 16, 2018
Final Disposition Processed
Jun 1, 2018
Final Decision Transaction Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24